BRPI0514482A - composições herbais para a prevenção ou tratamento de incontinência urinária e bexiga superativa - Google Patents

composições herbais para a prevenção ou tratamento de incontinência urinária e bexiga superativa

Info

Publication number
BRPI0514482A
BRPI0514482A BRPI0514482-5A BRPI0514482A BRPI0514482A BR PI0514482 A BRPI0514482 A BR PI0514482A BR PI0514482 A BRPI0514482 A BR PI0514482A BR PI0514482 A BRPI0514482 A BR PI0514482A
Authority
BR
Brazil
Prior art keywords
urinary incontinence
prevention
treatment
herbal compositions
overactive bladder
Prior art date
Application number
BRPI0514482-5A
Other languages
English (en)
Inventor
Tracey Anne Seipel
Original Assignee
Biolog Health Solutions Pty Lt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolog Health Solutions Pty Lt filed Critical Biolog Health Solutions Pty Lt
Publication of BRPI0514482A publication Critical patent/BRPI0514482A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSIçõES HERBAIS PARA A PREVENçãO OU TRATAMENTO DE INCONTINêNCIA URINáRIA E BEXIGA SUPERATIVA. A presente invenção refere-se a composições de ervas para prevenção ou tratamento de distúrbios do sistema urogenital, por exemplo, incontinência urinária, enurese (por exemplo, molhar a cama), hiperplasia benigna da próstata, cálculos urinários, cistite, infecção do trato urinário e bexiga superativa. Especificamente, a invenção fornece composições, que contêm C. nurvala e E. arvense, e métodos de uso da mesma.
BRPI0514482-5A 2004-08-18 2005-08-18 composições herbais para a prevenção ou tratamento de incontinência urinária e bexiga superativa BRPI0514482A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60253004P 2004-08-18 2004-08-18
PCT/IB2005/003370 WO2006018743A2 (en) 2004-08-18 2005-08-18 Herbal compositions for the prevention or treatment of urinary incontinence and overactive bladder

Publications (1)

Publication Number Publication Date
BRPI0514482A true BRPI0514482A (pt) 2008-06-17

Family

ID=35907785

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514482-5A BRPI0514482A (pt) 2004-08-18 2005-08-18 composições herbais para a prevenção ou tratamento de incontinência urinária e bexiga superativa

Country Status (13)

Country Link
US (1) US7378115B2 (pt)
EP (1) EP1778259A2 (pt)
JP (1) JP2008509988A (pt)
KR (1) KR20070046930A (pt)
CN (1) CN101039688A (pt)
AU (1) AU2005273544B2 (pt)
BR (1) BRPI0514482A (pt)
CA (1) CA2577654A1 (pt)
EA (1) EA200700467A1 (pt)
IL (1) IL181369A0 (pt)
MX (1) MX2007002080A (pt)
WO (1) WO2006018743A2 (pt)
ZA (1) ZA200702007B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007141661A2 (en) * 2006-02-22 2007-12-13 Tracey Anne Seipel Herbal compositions for the prevention or treatment of benign prostatic hyperplasia
WO2007144778A2 (en) * 2006-02-22 2007-12-21 Biologic Health Solutions Pty Ltd. Herbal compositions for the prevention or treatment of a urinary tract infection
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8623839B2 (en) * 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
KR101362539B1 (ko) * 2011-10-11 2014-02-14 씨제이제일제당 (주) 과민성방광 증후군 예방 및 치료용 조성물
EP2772252B1 (en) * 2011-10-26 2020-03-18 Hisamitsu Pharmaceutical Co., Inc. Oxybutynin-containing transdermal absorption preparation
CA2859462C (en) * 2011-12-23 2021-08-03 Tracey Anne Seipel Herbal compositions for the prevention or treatment of urinary incontinence and overactive bladder
US9682115B2 (en) * 2012-04-02 2017-06-20 Seipel Group Pty Ltd Herbal compositions for the prevention or treatment of benign prostatic hyperplasia and related disorders
US9752174B2 (en) * 2013-05-28 2017-09-05 Purecircle Sdn Bhd High-purity steviol glycosides
JP6366279B2 (ja) * 2013-01-22 2018-08-01 花王株式会社 過活動膀胱の予防又は改善剤
EP3120847B1 (en) * 2014-03-17 2023-11-08 Shanghai Institute of Materia Medica, Chinese Academy of Sciences Glechoma longituba extract for the treatment of kidney diseases or diabetes mellitus
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
CN104922576A (zh) * 2015-07-15 2015-09-23 龚灿锋 一种治疗肾结石的中药
CN104922577A (zh) * 2015-07-15 2015-09-23 龚灿锋 一种治疗畜禽泌尿结石的中药组合物
CN105232990A (zh) * 2015-11-13 2016-01-13 济南新时代医药科技有限公司 一种治疗bph合并膀胱过度活动症的中药
CN105232989A (zh) * 2015-11-13 2016-01-13 济南新时代医药科技有限公司 一种治疗老年女性特发性膀胱过度活动症的中药
US11213561B2 (en) * 2017-06-09 2022-01-04 Rox IP Pty Ltd. Herbal methods for the improvement of sleep, social interaction, concern or worry
US20210268057A1 (en) * 2020-02-27 2021-09-02 Innovus Pharmaceuticals, Inc. Compositions and methods for treating urinary conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4330773A1 (de) * 1993-09-10 1995-03-16 Laevosan Gmbh & Co Kg Blockierung der Anlagerung von Keimen an menschliche Zellen
US6277396B1 (en) * 2000-05-11 2001-08-21 Maximum Human Performance, Inc. Dietary supplement containing a thermogenic substance and an adrenal support substance
US20040147459A1 (en) * 2002-10-23 2004-07-29 Joseph Oneal Method and composition for maintaining urinary tract health in the face of infections
US7025998B2 (en) * 2003-05-30 2006-04-11 Rotta Research Laboratorium S.P.A. Phytoestrogens and probiotic for women's health

Also Published As

Publication number Publication date
CA2577654A1 (en) 2006-02-23
EP1778259A2 (en) 2007-05-02
CN101039688A (zh) 2007-09-19
IL181369A0 (en) 2007-07-04
AU2005273544A1 (en) 2006-02-23
MX2007002080A (es) 2007-07-19
ZA200702007B (en) 2008-12-31
EA200700467A1 (ru) 2007-12-28
US7378115B2 (en) 2008-05-27
US20060040004A1 (en) 2006-02-23
WO2006018743A2 (en) 2006-02-23
WO2006018743A3 (en) 2006-06-22
JP2008509988A (ja) 2008-04-03
AU2005273544B2 (en) 2011-02-10
KR20070046930A (ko) 2007-05-03

Similar Documents

Publication Publication Date Title
BRPI0514482A (pt) composições herbais para a prevenção ou tratamento de incontinência urinária e bexiga superativa
WO2008028076A3 (en) Therapeutic devices for the treatment of various conditions of a female individual
WO2007011962A3 (en) Treatment of cancer
BRPI0007487B8 (pt) difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase
WO2008021210A3 (en) Methods and compositions for the treatment of neurodegenerative disorders
NO20060398L (no) Anvendelse av en kombinasjon av en epidermal vekstfaktor reseptor kinase inhibitor og cytotoksiske midler for behandling og hemming av kreft
WO2006024018A3 (en) Compositions for treating nociceptive pain
WO2007112073A3 (en) Methods for modulating bladder function
WO2008036846A3 (en) Combination comprising an hmg-coa reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis
WO2004066990A3 (en) Methods of treating lower urinary tract disorders using sodium channel modulators
EA200301104A1 (ru) Антиангиогенная комбинированная терапия для лечения онкологических заболеваний
DE50109156D1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
BRPI0506970A (pt) derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior
WO2002055530A3 (en) Transcobalamin binding conjugates useful for treating abnormal cellular proliferation
ATE266031T1 (de) Verfahren und verbindungen zur behandlung proliferativer erkrankungen
WO2002039994A3 (en) Methods for the treatment and prevention of urinary stone disease
BR0212714A (pt) Combinação de opiáceos selecionados com antagonistas muscarìnicos destinados ao tratamento da incontinência urinária
WO2008022155A3 (en) Methods of identifying agents for treating neurological disorders
WO2006104870A3 (en) Methods of treating benign prostatic hyperplasia or lower urinary track symptoms by using pde 5 inhibitors
EP1784186A4 (en) METHOD FOR TREATING AND PREVENTING EFFECTS AND ENTIRE INCONTINENCE
BR0115882A (pt) Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
ATE456053T1 (de) Na+, k+-atpase-expression bei zervixdysplasie und krebs
BRPI0412868A (pt) compostos de sulfonildihidroimidazopiridinona como ligantes da 5-hidroxitriptamina-6
BRPI0408238A (pt) anticorpo, método de detectar cáncer, conjunto para detecção de cáncer, e, composição farmacêutica para tratar cáncer

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]